Skip to main content
SupplementScience

Benefits of Alpha Lipoic Acid (Liver Support)

This content is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any supplement. Full disclaimer

Evidence-Based Benefits

  • Glutathione regeneration — ALA reduces oxidized glutathione (GSSG) back to reduced glutathione (GSH), effectively recycling the liver's master antioxidant. This mechanism amplifies hepatic antioxidant capacity beyond what GSH supplementation alone provides (Packer et al., 1995).
  • NAFLD improvement — a double-blind RCT by Vajro et al. (2011, n=40) demonstrated that 800 IU vitamin E combined with ALA significantly reduced ALT and improved liver ultrasonography in pediatric NAFLD patients. Separately, Koh et al. (2011, n=50) showed 1200mg/day ALA reduced body weight and ALT in obese NAFLD patients.
  • Insulin sensitization — ALA improves insulin signaling by activating AMPK and enhancing glucose transporter (GLUT4) translocation. Jacob et al. (1999, n=74) showed 600mg/day IV ALA improved insulin sensitivity by 27% in type 2 diabetics — relevant because insulin resistance drives NAFLD.
  • Mitochondrial protection — as a cofactor for pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase, ALA is essential for mitochondrial energy production and protects these organelles from oxidative damage in hepatocytes.
  • Heavy metal chelation — ALA chelates mercury, arsenic, cadmium, and excess iron due to its dithiol structure, supporting detoxification of these hepatotoxic metals (Patrick, 2002).

What the Research Says

Alpha lipoic acid's hepatoprotective properties stem from its unique position as a universal antioxidant that operates in both aqueous and lipid environments. Packer et al. (1995) published the foundational review establishing ALA's role in regenerating glutathione and other antioxidants. For NAFLD specifically, Koh et al. (2011) showed 1200mg/day ALA reduced body weight and liver enzymes in obese patients, while multiple studies have confirmed ALA's insulin-sensitizing effects are relevant to fatty liver pathogenesis. Jacob et al. (1999) demonstrated significant improvements in insulin sensitivity with 600mg/day in type 2 diabetics. In Europe, ALA has pharmaceutical status for diabetic neuropathy (Thioctacid), and its liver-protective applications are increasingly recognized. The R-enantiomer is the biologically active form and is roughly twice as potent as the racemic mixture commonly sold.

Related Conditions

Liver Health
Full Alpha Lipoic Acid (Liver Support) Guide

References

  1. (). Alpha-lipoic acid as a biological antioxidant. Free Radical Biology and Medicine. DOI
  2. (). Effects of alpha-lipoic acid on body weight in obese subjects. American Journal of Medicine. DOI
  3. (). Oral administration of RAC-alpha-lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: a placebo-controlled pilot trial. Free Radical Biology and Medicine. DOI
  4. (). Mercury toxicity and antioxidants: Part 1: role of glutathione and alpha-lipoic acid in the treatment of mercury toxicity. Alternative Medicine Review.